CA 051
Alternative Names: CA-051Latest Information Update: 06 Oct 2020
At a glance
- Originator Concentric Analgesics
- Class Non-opioid analgesics; Small molecules
- Mechanism of Action TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer pain; Postoperative pain
Most Recent Events
- 23 Sep 2020 Preclinical trials in Cancer pain in USA (unspecified route) (Concentric Analgesics pipeline September 2020)
- 23 Sep 2020 Preclinical trials in Postoperative pain in USA (unspecified route) (Concentric Analgesics pipeline September 2020)
- 23 Sep 2020 Concentric analgesics plans a phase I trial for Cancer pain and Postoperative pain in 2020